Sensitivity of LM and IEM according to amyloidosis type
| Amyloidosis type . | n . | LM % (95% CI) . | IEM % (95% CI) . |
|---|---|---|---|
| AL | 320 | 80.9 (76.1-85) | 79.4 (74.4-83.6)* |
| κ | 99 | 73.7 (63.8-81.8)† | 70.7 (60.6-79.2)‡ |
| λ | 221 | 84.2 (78.5-88.6)† | 83.3 (77.5-87.8)‡ |
| AA | 69 | 76.8 (64.8-85.8) | 76.8 (64.8-85.8)§ |
| ATTR | 30 | 66.7 (47.1-82.1) | 43.3 (26-62.3)*§ |
| Mutated ATTR | 25 | 72 (50.4-87.1) | 40 (21.8-61.1) |
| Senile ATTR | 5 | 40 (7.2-83) | 40 (7.2-83) |
| Others | 4 | 25 (1.3-78.1) | 0 |
| Amyloidosis type . | n . | LM % (95% CI) . | IEM % (95% CI) . |
|---|---|---|---|
| AL | 320 | 80.9 (76.1-85) | 79.4 (74.4-83.6)* |
| κ | 99 | 73.7 (63.8-81.8)† | 70.7 (60.6-79.2)‡ |
| λ | 221 | 84.2 (78.5-88.6)† | 83.3 (77.5-87.8)‡ |
| AA | 69 | 76.8 (64.8-85.8) | 76.8 (64.8-85.8)§ |
| ATTR | 30 | 66.7 (47.1-82.1) | 43.3 (26-62.3)*§ |
| Mutated ATTR | 25 | 72 (50.4-87.1) | 40 (21.8-61.1) |
| Senile ATTR | 5 | 40 (7.2-83) | 40 (7.2-83) |
| Others | 4 | 25 (1.3-78.1) | 0 |
Statistical significance between groups: *P < .001, †P = .03, ‡P = .016, and §P = .002.